Catalyst Wire Dossier Catalyst Wire Dossier

Human Umbilical Cord-derived Mesenchymal Stem Cells (hUC-MSCs)

mesenchymal stem cells · Beijing 302 Hospital
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Human Umbilical Cord-derived Mesenchymal Stem Cells (hUC-MSCs), covering 2024-10-18 to 2024-10-18. Get the full timeline:

Most recent: Clinical Trial Update: Human Umbilical Cord-derived Mesenchymal Stem Cells for Decompensated Cirrhosis (MSC-DLC-2) [Phase 2]

See pricing